
Respicardia
Developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health.
Employees
Enterprise value
$234—351m
Authorizing premium user...
Developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health.